Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Lymphoblastic Leukemia(ALL)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04731974
What this trial is testing

Acute Concussion and Melatonin

Who this might be right for
Concussion, MildConcussion, BrainPediatric ALL
Children's National Research Institute 254
Large-scale testing (Phase 3)Study completedNCT00430118
What this trial is testing

Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
University Hospital Schleswig-Holstein 4,559
Not applicableStudy completedNCT05190952
What this trial is testing

Dexamethasone & Ketamine as Adjuvants to Bupivacaine for Incisional Infiltration in Pediatric Abdominal Operations

Who this might be right for
Pediatric ALL
Ain Shams University 150
Large-scale testing (Phase 3)UnknownNCT03553238
What this trial is testing

Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALL

Who this might be right for
Leukemia, AcuteLeukemia, T CellLeukemia, Lymphoblastic
Nanfang Hospital, Southern Medical University 70
Post-approval studies (Phase 4)Study completedNCT00198991
What this trial is testing

German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003)

Who this might be right for
Adult Acute Lymphocytic Leukemia
Goethe University 1,883
Testing effectiveness (Phase 2)Study completedNCT02362035
What this trial is testing

ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies

Who this might be right for
Follicular Lymphoma (FL)CLLSmall Lymphocytic Lymphoma (SLL)+10 more
Acerta Pharma BV 161
Not applicableLooking for participantsNCT07813208
What this trial is testing

Ph+ ALL in Chinese Children: Diagnosis, Treatment, and Survival

Who this might be right for
Acute Lymphoblastic Leukemia, Pediatric
The Children's Hospital of Zhejiang University School of Medicine 500
Not applicableEnded earlyNCT00594308
What this trial is testing

In-Vivo Activated T-Cell Depletion to Prevent GVHD

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+7 more
Indiana University 10
Testing effectiveness (Phase 2)Study completedNCT00440726
What this trial is testing

Bortezomib With Chemotherapy for Relapsed Pediatric Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Acute Lymphoblastic Leukemia
Therapeutic Advances in Childhood Leukemia Consortium 31
Not applicableStudy completedNCT06170385
What this trial is testing

Pediatric Early Rehabilitation in Acute Lymphoblastic Leukemia

Who this might be right for
NeoplasmsPediatric CancerPhysical Therapy+1 more
University of Alberta 10
Testing effectiveness (Phase 2)Study completedNCT00118326
What this trial is testing

Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease

Who this might be right for
Kidney CancerLeukemiaLymphoma+3 more
Fred Hutchinson Cancer Center
Early research (Phase 1)Study completedNCT00125840
What this trial is testing

Clofarabine in Adult Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorsLeukemia, Lymphocytic, Acute, PediatricLeukemia, Lymphocytic, Acute, Adult+3 more
Genzyme, a Sanofi Company
Not applicableLooking for participantsNCT05366569
What this trial is testing

Bio-CAR-T BS Study

Who this might be right for
Diffuse Large B Cell Lymphoma (DLBCL)Primary Mediastinal Large B-cell Lymphoma (PMBCL)Acute Lymphoblastic Leukemia (ALL)
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 45
Early research (Phase 1)Ended earlyNCT03110354
What this trial is testing

DS-3201b for Acute Myelogenous Leukemia (AML) or Acute Lymphocytic Leukemia (ALL)

Who this might be right for
Leukemia, Myeloid, AcuteLeukemia, Lymphocytic, Acute
Daiichi Sankyo 28
Not applicableUnknownNCT02759822
What this trial is testing

Haploidentical Hematopoietic Stem Cell Transplantation for Acute Leukemias

Who this might be right for
Leukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-Lymphoma
Leonardo Javier Arcuri 30
Early research (Phase 1)Study completedNCT00004002
What this trial is testing

PS-341 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
NYU Langone Health
Testing effectiveness (Phase 2)Study completedNCT00462605
What this trial is testing

MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia

Who this might be right for
Adult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)+25 more
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)UnknownNCT03467256
What this trial is testing

CD19 T-CAR for Treatment of Children and Young Adults With r/r B-ALL

Who this might be right for
B-cell Acute Lymphoblastic LeukemiaAcute Lymphocytic Leukemia, Pediatric
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 18
Not applicableUnknownNCT04120896
What this trial is testing

Karate or Kung Fu?

Who this might be right for
Childhood ALL
The University of Hong Kong 52
Early research (Phase 1)WithdrawnNCT05037669
What this trial is testing

Programmed Allogeneic CRISPR-edited T Cells Engineered to Express Anti-CD19 Chimeric Antigen Receptor (PACE CART19) in Patients With Relapsed Or Refractory CD19+ Leukemia and Lymphoma

Who this might be right for
Acute Lymphoblastic LeukemiaChronic Lymphocytic LeukemiaNon Hodgkin Lymphoma
University of Pennsylvania
Next Page